Exclusive

Publication

Byline

Location

Clinical Trial: A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571928) titled 'A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia' on A... Read More


Clinical Trial: A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571200) titled 'A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Scler... Read More


Clinical Trial: Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571889) titled 'Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for C... Read More


Clinical Trial: An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO(R) (Rozanolixizumab)

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570589) titled 'An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myas... Read More


Clinical Trial: Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571460) titled 'Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Po... Read More


Clinical Trial: A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570862) titled 'A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis' on Apr... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 7 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post... Read More